Skip to content

Exploratory Study Using a New Head-only PET Scanner / ExploreNeuroLF

Exploratory Study of NeuroLF, an Investigational Medical Device Without CE Marking for PET Imaging of the Human Brain

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06344871
Enrollment
70
Registered
2024-04-03
Start date
2024-03-13
Completion date
2025-12-31
Last updated
2025-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Diseases

Brief summary

The NeuroLF prototype is a small aperture PET scanner. The NeuroLF prototype will be used with patients, which have just finished their regularly scheduled PET examination on a clinical whole body PET system. The radioactive tracer used for this procedure will still be active. This remaining acitivity will be used for an image acquisition with the NeuroLF prototype without the need for an additional radioactive tracer dose. The control intervention is be a brain PET scan as part of standard clinical routine. It will be done immediately before the scan on the NeuroLF prototype.

Interventions

DEVICENeuroLF

NeuroLF Scan

DEVICEConventional PET scan

Scan on conventional PET system

Sponsors

University of Zurich
CollaboratorOTHER
University of Leipzig
CollaboratorOTHER
Positrigo AG
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Capable of giving Informed Consent as documented by signature (Appendix Informed Consent Form). * Ability to sit still in the head-only PET scanner for 15 minutes. * Are scheduled to receive a regular brain PET scan as part of clinical routine. * Male and Female patients 18 years to 80 years of age.

Exclusion criteria

* Contraindications to PET examination, * Patient height smaller than 160 cm or taller than 200 cm, * Patient weight more than 120 kg, * Patient cannot sit upright for at least 15 minutes, * Metal implants in the head, * Pregnant or Breastfeeding women, * Known or suspected non-compliance, drug or alcohol abuse, * Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant, * Participation in another study with investigational drug/device within the 30 days preceding and during the present study, * Previous enrolment into the current study, * Enrolment of the investigator, his/her family members, employees and other dependent persons.

Design outcomes

Primary

MeasureTime frameDescription
PET Image of the Brain1 dayThe primary outcome will be a PET image of the brain for each participant taken on NeuroLF. It will be compared against the image taken by the conventional PET machine by a trained physician and judged by whether it could be used for diagnosis and further analysis.

Secondary

MeasureTime frameDescription
Ease of Placement (Usability)1 day100-Visual Analog Scale question how easy it was to place the patient on NeuroLF vs. the comparator
Usage of accessories for patient placement (Usability)1 dayMultiple Choice question which accessories were used to stabilize the patient.

Countries

Germany, Switzerland

Contacts

Primary ContactJannis Fischer, Dr.
jannis.fischer@positrigo.com+41445155331
Backup ContactDiego Stohrer, MSc.
diego.stohrer@positrigo.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026